本页面由Tiger Trade Technology Pte. Ltd.提供服务

Americann Inc.

0.0001
0.0000
成交量:1,400.00
成交额:0.14
市值:2,439.20
市盈率:0.00
高:0.0001
开:0.0001
低:0.0001
收:0.0001
52周最高:0.1201
52周最低:0.0000
股本:2,439.20万
流通股本:1,373.84万
量比:1.18
换手率:0.01%
股息:- -
股息率:- -
每股收益(TTM):-0.0976
每股收益(LYR):-0.0514
净资产收益率:-54.80%
总资产收益率:-5.74%
市净率:0.00
市盈率(LYR):0.00

数据加载中...

公司资料

公司名字:
Americann Inc.
交易所:
EXPERT
成立时间:
2010
员工人数:
3
公司地址:
1555 Blake Street,Unit 502,Denver,Colorado,United States
邮编:
80202
电话:
传真:
- -
简介:
AmeriCann, Inc. develops, owns and supports advanced medical cannabis cultivation and processing facilities nationwide. The Company has a multi-market portfolio of over 1,000,000 square feet of sustainable cannabis production infrastructure in various stages of development. AmeriCann's team includes experts in traditional horticulture, lean manufacturing, medical research, facility construction, regulatory compliance, security, marijuana cultivation and genetics, extraction processes, and infused product development. To support local businesses that seek to serve cannabis patients in their communities we initiated the AmeriCann Preferred Partner Program. Through this program we provide an essential set of resources including advance cultivation facilities, access to a team of experts and in certain cases, capital for our partner's businesses. In addition, AmeriCann's team has been instrumental in winning cannabis licenses in competitive application processes throughout the country. This support is designed to assist our Preferred Partners in newly regulated markets. AmeriCann leases facilities to our Preferred Partners that are designed with AmeriCann's propriety cultivation and processing system called "Cannopy." AmeriCann developed Cannopy with experts from traditional horticulture, lean manufacturing, regulatory compliance and cannabis cultivation. Cannopy includes automation throughout the production life-cycle, customized workflow processes, monitoring and controls, and top-line security systems. Cannopy empowers Preferred Partners to consistently produce medical marijuana for patients at the lowest cost in the most efficient, compliant manner. We provide initial and on-going training, policies, practices and procedures to operate the state-of-the-art facilities. The expanding cannabis industry requires extensive real estate to meet the growing needs of patients. AmeriCann utilizes a proven strategy for identifying, acquiring and developing real estate specifically suited for cannabis operations. AmeriCann assists our Preferred Partners with the identification, design, permitting, acquisition, development and operation of scalable infrastructure to cultivate and to dispense medical marijuana in regulated markets. As an early market participant, the Company plans to leverage its leadership in a formative industry to establish a dominant position as the cannabis industry expands.